최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Antiviral research, v.147, 2017년, pp.131 - 141
Du, Ruikun (Corresponding author. State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Xiaohongshan 44, Wuchang, Wuhan, 430071, PR China.) , Wang, Lili , Xu, Hao , Wang, Zhiying , Zhang, Tao , Wang, Manli , Ning, Yunjia , Deng, Fei , Hu, Zhihong , Wang, Hualin , Li, Yi
Abstract The worldwide prevalence of herpes simplex virus (HSV) and the shortage of efficient vaccines and novel therapeutic strategies against HSV are widely global concerns. The abundance on the virion and the major stimulus for the virus-neutralizing antibodies makes gD a predominant candidate f...
Awasthi S. Friedman H.M. Status of prophylactic and therapeutic genital herpes vaccines Curr. Opin. Virol. 6 2014 6 12 24631871
Bag P. Ojha D. Mukherjee H. Halder U.C. Mondal S. Chandra N.S. Nandi S. Sharon A. Sarkar M.C. Chakrabarti S. Chattopadhyay D. An indole alkaloid from a tribal folklore inhibits immediate early event in HSV-2 infected cells with therapeutic efficacy in vaginally infected mice PloS One 8 2013 e77937
Barnabas R.V. Celum C. Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions Curr. HIV Res. 10 2012 228 237 22384842
Bender F.C. Samanta M. Heldwein E.E. de Leon M.P. Bilman E. Lou H. Whitbeck J.C. Eisenberg R.J. Cohen G.H. Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions J. Virol. 81 2007 3827 3841 17267495
Burkhart M.D. Kayman S.C. He Y. Pinter A. Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU J. Virol. 77 2003 3993 4003 12634359
Cairns T.M. Huang Z.Y. Whitbeck J.C. Ponce de Leon M. Lou H. Wald A. Krummenacher C. Eisenberg R.J. Cohen G.H. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans J. Virol. 88 2014 12612 12622 25142599
Cena-Diez R. Vacas-Cordoba E. Garcia-Broncano P. de la Mata F.J. Gomez R. Maly M. Munoz-Fernandez M.A. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action Int. J. Nanomed. 11 2016 2147 2162
Cleary K.L. Pare E. Stamilio D. Macones G.A. Type-specific screening for asymptomatic herpes infection in pregnancy: a decision analysis BJOG Int. J. Obstet. Gynaecol. 112 2005 731 736
Co M.S. Deschamps M. Whitley R.J. Queen C. Humanized antibodies for antiviral therapy Proc. Natl. Acad. Sci. U. S. A. 88 1991 2869 2873 1849279
Cocchi F. Fusco D. Menotti L. Gianni T. Eisenberg R.J. Cohen G.H. Campadelli-Fiume G. The soluble ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry Proc. Natl. Acad. Sci. U. S. A. 101 2004 7445 7450 15123804
de StGroth S.F. Scheidegger D. Production of monoclonal antibodies: strategy and tactics J. Immunol. Methods 35 1980 1 21 7009747
Dix R.D. Pereira L. Baringer J.R. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease Infect. Immun. 34 1981 192 199 6271681
Domeika M. Bashmakova M. Savicheva A. Kolomiec N. Sokolovskiy E. Hallen A. Unemo M. Ballard R.C. Eastern European Network for, S., Reproductive, H Guidelines for the laboratory diagnosis of genital herpes in eastern European countries Euro Surveill. Bull. Eur. les Mal. Transm. Eur. Commun. Disease Bull. 15 2010
Dropulic L.K. Cohen J.I. The challenge of developing a herpes simplex virus 2 vaccine Expert Rev. Vaccines 11 2012 1429 1440 23252387
Eisenberg R.J. Atanasiu D. Cairns T.M. Gallagher J.R. Krummenacher C. Cohen G.H. Herpes virus fusion and entry: a story with many characters Viruses 4 2012 800 832 22754650
Evan G.I. Lewis G.K. Ramsay G. Bishop J.M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product Mol. Cell. Biol. 5 1985 3610 3616 3915782
Everett R.D. HSV-1 biology and life cycle Methods Mol. Biol. 1144 2014 1 17 24671673
Fotouhi F. Soleimanjahi H. Roostaee M.H. Dalimi Asl A. Expression of the herpes simplex virus type 2 glycoprotein D in baculovirus expression system and evaluation of its immunogenicity in Guinea pigs Iran. Biomed. J. 12 2008 59 66 18506211
Freeman E.E. Weiss H.A. Glynn J.R. Cross P.L. Whitworth J.A. Hayes R.J. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies Aids 20 2006 73 83 16327322
Fusco D. Forghieri C. Campadelli-Fiume G. The pro-fusion domain of herpes simplex virus glycoprotein D (gD) interacts with the gD N terminus and is displaced by soluble forms of viral receptors Proc. Natl. Acad. Sci. U. S. A. 102 2005 9323 9328 15972328
Hooks J.J. Burns W. Hayashi K. Geis S. Notkins A.L. Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection Infect. Immun. 14 1976 1172 1178 185150
Isola V.J. Eisenberg R.J. Siebert G.R. Heilman C.J. Wilcox W.C. Cohen G.H. Fine mapping of antigenic site II of herpes simplex virus glycoprotein D J. Virol. 63 1989 2325 2334 2467994
Krawczyk A. Krauss J. Eis-Hubinger A.M. Daumer M.P. Schwarzenbacher R. Dittmer U. Schneweis K.E. Jager D. Roggendorf M. Arndt M.A. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus J. Virol. 85 2011 1793 1803 21123390
Krummenacher C. Nicola A.V. Whitbeck J.C. Lou H. Hou W. Lambris J.D. Geraghty R.J. Spear P.G. Cohen G.H. Eisenberg R.J. Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry J. Virol. 72 1998 7064 7074 9696799
Lazear E. Whitbeck J.C. Ponce-de-Leon M. Cairns T.M. Willis S.H. Zuo Y. Krummenacher C. Cohen G.H. Eisenberg R.J. Antibody-induced conformational changes in herpes simplex virus glycoprotein gD reveal new targets for virus neutralization J. Virol. 86 2012 1563 1576 22130533
Looker K.J. Garnett G.P. Schmid G.P. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection Bull. World Health Organ. 86 2008 805 812 A 18949218
Looker K.J. Magaret A.S. Turner K.M. Vickerman P. Gottlieb S.L. Newman L.M. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012 PloS One 10 2015 e114989
Morrison L.A. Knipe D.M. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1 Virology 220 1996 402 413 8661391
Muggeridge M.I. Wilcox W.C. Cohen G.H. Eisenberg R.J. Identification of a site on herpes simplex virus type 1 glycoprotein D that is essential for infectivity J. Virol. 64 1990 3617 3626 1695252
Navarro D. Paz P. Pereira L. Domains of herpes simplex virus I glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion Virology 186 1992 99 112 1370130
Nicola A.V. Ponce de Leon M. Xu R. Hou W. Whitbeck J.C. Krummenacher C. Montgomery R.I. Spear P.G. Eisenberg R.J. Cohen G.H. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM J. Virol. 72 1998 3595 3601 9557640
Overall J.C. Jr. Herpes simplex virus infection of the fetus and newborn Pediatr. Ann. 23 1994 131 136 8015861
Parr M.B. Kepple L. McDermott M.R. Drew M.D. Bozzola J.J. Parr E.L. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2 Lab. Investig. J. Tech. Methods Pathol. 70 1994 369 380
Pereira L. Klassen T. Baringer J.R. Type-common and type-specific monoclonal antibody to herpes simplex virus type 1 Infect. Immun. 29 1980 724 732 6260657
Pirestani M. Dalimi A. Sarvi S. Khoramabadi N. Evaluation of immunogenicity of novel isoform of EG95 (EG95-5G1) from Echinococcus granulosus in BALB/C mice Iran. J. Parasitol. 9 2014 491 502 25759730
Sanna P.P. De Logu A. Williamson R.A. Hom Y.L. Straus S.E. Bloom F.E. Burton D.R. Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV Virology 215 1996 101 106 8553581
Sartori E. Calistri A. Salata C. Del Vecchio C. Palu G. Parolin C. Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages Virol. J. 8 2011 166 21486479
Shin H. Iwasaki A. Generating protective immunity against genital herpes Trends Immunol. 34 2013 487 494 24012144
Smith J.S. Herrero R. Bosetti C. Munoz N. Bosch F.X. Eluf-Neto J. Castellsague X. Meijer C.J. Van den Brule A.J. Franceschi S. Ashley R. International Agency for Research on Cancer Multicentric Cervical Cancer Study, G Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer J. Natl. Cancer Inst. 94 2002 1604 1613 12419786
Steiner I. Benninger F. Update on herpes virus infections of the nervous system Curr. Neurol. Neurosci. Rep. 13 2013 414 24142852
Whitbeck J.C. Muggeridge M.I. Rux A.H. Hou W. Krummenacher C. Lou H. van Geelen A. Eisenberg R.J. Cohen G.H. The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain J. Virol. 73 1999 9879 9890 10559300
Wibmer C.K. Moore P.L. Morris L. HIV broadly neutralizing antibody targets Curr. Opin. HIV AIDS 10 2015 135 143 25760932
Zeitlin L. Whaley K.J. Sanna P.P. Moench T.R. Bastidas R. De Logu A. Williamson R.A. Burton D.R. Cone R.A. Topically applied human recombinant monoclonal IgG1 antibody and its Fab and F(ab')2 fragments protect mice from vaginal transmission of HSV-2 Virology 225 1996 213 215 8918548
Zeng F. Hon C.C. Yip C.W. Law K.M. Yeung Y.S. Chan K.H. Malik Peiris J.S. Leung F.C. Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunit FEBS Lett. 580 2006 5612 5620 16989815
Zhao Y. Cao X. Tang J. Zhou L. Gao Y. Wang J. Zheng Y. Yin S. Wang Y. A novel multiplex real-time PCR assay for the detection and quantification of HPV16/18 and HSV1/2 in cervical cancer screening Mol. Cell. Probes 26 2012 66 72 22293505
Zou Z. Liu J. Wang Z. Deng F. Wang H. Hu Z. Wang M. Zhang T. Characterization of two monoclonal antibodies, 38F10 and 44D11, against the major envelope fusion protein of Helicoverpa armigera nucleopolyhedrovirus Virol. Sin. 31 2016 490 499 27995421
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.